Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment

Author:

Baljevic Muhamed1ORCID,Gasparetto Cristina2,Schiller Gary J.3,Tuchman Sascha A.4,Callander Natalie S.5,Lentzsch Suzanne6,Monge Jorge7,Kotb Rami8,Bahlis Nizar J.9ORCID,White Darrell10,Chen Christine I.11,Sutherland Heather J.12,Madan Sumit13,LeBlanc Richard14,Sebag Michael15,Venner Christopher P.16,Bensinger William I.17,Biran Noa18ORCID,DeCastro Andrew19,Van Domelen Dane R.19,Zhang Chris19,Shah Jatin J.19,Shacham Sharon19,Kauffman Michael G.19,Bentur Ohad S.19,Lipe Brea20

Affiliation:

1. Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA

2. Duke Cancer Institute Duke University Durham North Carolina USA

3. Hematological Malignancy/Stem Cell Transplant Program University of California ‐ Los Angeles David Geffen School of Medicine Los Angeles California USA

4. Department of Medicine Division of Hematology The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

5. Division of Hematology/Oncology, Department of Medicine University of Wisconsin‐Madison School of Medicine and Public Health Madison Wisconsin USA

6. Columbia University Medical Center New York New York USA

7. Weill Cornell Medicine New York New York USA

8. Medical Oncology and Hematology CancerCare Manitoba Winnipeg Manitoba Canada

9. Arnie Charbonneau Cancer Research Institute University of Calgary Calgary Alberta Canada

10. Department of Medicine/Division of Hematology Dalhousie University Halifax Nova Scotia Canada

11. Princess Margaret Cancer Centre Toronto Ontario Canada

12. Division of Hematology Vancouver General Hospital Vancouver British Columbia Canada

13. Banner MD Anderson Cancer Center Gilbert Arizona USA

14. Maisonneuve‐Rosemont Hospital University of Montreal Montreal Québec Canada

15. Division of Hematology McGill University Health Centre Montreal Québec Canada

16. Cross Cancer Institute University of Alberta Edmonton Alberta Canada

17. Center for Blood Disorders and Stem Cell Transplantation Swedish Cancer Institute Seattle Washington USA

18. John Theurer Cancer Center, Hackensack Meridian Health Hackensack University Medical Center Hackensack New Jersey USA

19. Karyopharm Therapeutics Inc. Newton Massachusetts USA

20. Wilmot Cancer Institute University of Rochester Medical Center Rochester New York USA

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3